Compared with the vehicle-transfected group, Ad5/35-tk/GCV inhibited the tumor growth of CD46-overexpressing cells, but revealed reduced tumor cytotoxicity in CD46-suppressed cells (p = 0.005 by a repeated-measures ANOVA). This evidence concerns the gene CD46 and neoplasm.